New tuberculosis vaccine is developed

Jun 06, 2007

U.S. scientists have announced development of a vaccine to prevent tuberculosis, one of the world's most deadly diseases.

Colorado State University researchers said their vaccine triggers the body's immunity in a novel way -- by activating specific immune system functions that enhance the response to the bacterium that causes tuberculosis.

Although still in preliminary stages of testing, scientists said the vaccine would likely be effective against all strains of TB, including multi-drug and extensively drug resistant tuberculosis. In addition, preliminary evidence shows the vaccine has promise of working after exposure to tuberculosis, which no other tuberculosis vaccine in current development has achieved.

"This novel vaccine system provides the template to design a series of new tuberculosis vaccines that could be very inexpensive to make," said Professor Ian Orme, head of the research team that developed the vaccine. "The next stage is to test the vaccine for long-lasting immunity and its ability to boost existing vaccines."

Human trials for the vaccine are expected within two to three years.

Copyright 2007 by United Press International

Explore further: Discount generic drug programs grow over time

add to favorites email to friend print save as pdf

Related Stories

TB vaccine enters new clinical trials

Apr 23, 2009

(PhysOrg.com) -- The world’s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate ...

Recommended for you

Discount generic drug programs grow over time

1 hour ago

Generic discount drug programs (GDDPs, which charge nominal fees to fill prescriptions) have grown over time and their initial lower use by racial/ethnic minorities has evaporated, writes author Song Hee Hong, Ph.D., of the ...

Seniors successfully withdraw from meds

Sep 19, 2014

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

User comments : 0